Validation of a Digital Platform for Functional Respiratory Rehabilitation - Trial NCT06252818
Access comprehensive clinical trial information for NCT06252818 through Pure Global AI's free database. This phase not specified trial is sponsored by Bio-Sensing Solutions S.L. (DyCare) and is currently Not yet recruiting. The study focuses on COPD. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Bio-Sensing Solutions S.L. (DyCare)
Timeline & Enrollment
N/A
Mar 07, 2024
Dec 01, 2024
Primary Outcome
System Usability Scale (SUS),Satisfaction and Usability Questionnaire with Comprehensive Outpatient follow-up health applications (pSUAPP-S) for Patients,Satisfaction and Usability Questionnaire with Comprehensive Outpatient follow-up health applications (pSUAPP-S) for Healthcare Professionals
Summary
Chronic Obstructive Pulmonary Disease (COPD), characterized by persistent airflow limitation
 in the respiratory airways, is a chronic condition that affects millions of people worldwide.
 ReHub enables healthcare professionals to design therapeutic exercise programs for the
 treatment of COPD patients, as well as to analyze and monitor patient rehabilitation through
 the information and feedback provided via the platform. The main objective of the study is to
 evaluate the satisfaction and usability of the ReHub platform (for respiratory
 rehabilitation) among COPD patients and healthcare professionals. This is a single-center
 satisfaction and usability study on the usage and experience of the ReHub platform (for
 respiratory rehabilitation).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06252818
Device Trial